Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11660308 Pharmaceutical composition comprising dapagliflozin

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
May 14, 2021
0
Date of Patent
May 30, 2023
0
Patent Application Number
17302901
0
Patent Citations
‌
US Patent 8088743 Methods for treating obesity employing an SGLT2 inhibitor
0
‌
US Patent 8221786 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8361972 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8501698 Crystal structures of SGLT2 inhibitors and processes for preparing same
0
‌
US Patent 8518895 Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same
0
‌
US Patent 8535715 Bilayer tablet formulations
0
‌
US Patent 8592371 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
0
‌
US Patent 8603989 Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
0
‌
US Patent 8716251 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8772328 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11660308
0
Patent Primary Examiner
‌
Yih-Horng Shiao
0
CPC Code
‌
A61K 9/2009
0
‌
A61K 9/2031
0
‌
A61K 9/2054
0
‌
A61K 9/2018
0
‌
A61K 31/70
0

Find more entities like US Patent 11660308 Pharmaceutical composition comprising dapagliflozin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.